USPTO serial 98376011
MAYNE PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 1, 2025
- Examiner
- SIRIGNANO, EMMA MARIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MAYNE PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Mayne Pharma International Pty Ltd
SALISBURY SOUTH SA, AU
Other trademarks owned by Mayne Pharma International Pty Ltd
SALISBURY SOUTH, AU
Mayne Pharma International Pty Ltd
SALISBURY SOUTH SA, AU
Other trademarks owned by Mayne Pharma International Pty Ltd
Mayne Pharma International Pty Ltd
SALISBURY SOUTH SA, AU
Other trademarks owned by Mayne Pharma International Pty Ltd
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Melissa A. Nowak
Melissa A. Nowak Christensen O'Connor Johnson Kindness1201 Third Avenue, Suite 3600Seattle, WA 98101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations in the field of gynecology and women's health, namely, contraceptive preparations and oral contraceptives; hormone replacement therapy preparations containing estradiol and progesterone for use in treating the symptoms associated with menopause; pharmaceutical preparations for the treatment of vulval vaginal atrophy; antibiotic preparations; pharmaceutical preparations for the treatment of dermatological diseases and disorders; topical foam pharmaceutical preparations for treatment of steroid responsive dermatoses; pharmaceutical preparations for the treatment of rosacea and erythema associated with rosacea; pharmaceutical preparations for the treatment of psoriasis; antifungal preparations; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical substances and preparations for the treatment of cancer; dietary and nutritional supplements; vitamins | ACTIVE | Apr 27, 2018 |
| 010 | contraceptive apparatus in the field of gynecology and women's health | ACTIVE | Aug 21, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mayne Pharma International Pty Ltd
- Other trademarks owned by MAYNE PHARMA GROUP LIMITED
- Other trademarks owned by Mayne Pharma International Pty Ltd
- Other trademarks owned by Mayne Pharma International Pty Ltd
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named MAYNE PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 7, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 16, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 1, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 1, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 11, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 15, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 15, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 26, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 25, 2025 | IUAF | USE AMENDMENT FILED | — |
| Feb 11, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 24, 2025 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Jan 21, 2025 | APET | ASSIGNED TO PETITION STAFF | — |
| Dec 17, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 17, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 11, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 3, 2024 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Nov 19, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 19, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 19, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 19, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 19, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 29, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2024 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 24, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 7, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 6, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 6, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 6, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 1, 2024 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 1, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 25, 2024 | NWAP | NEW APPLICATION ENTERED | — |